Delivery Order SPE2DB20D2002-SPE2DB25FL50K
- Not listed
- The Defense Logistics Agency awarded a $2,031.08 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). The contract employs firm fixed pricing and requires completion by July 25, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,802.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $1,501.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,619.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made without...
- The Defense Logistics Agency awarded a $10,999.90 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $3,064.91 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). The contract, which is not set-aside, has an ultimate completion date of June 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery vehicle, leveraging...
- The Defense Logistics Agency awarded a $1,550.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $3,003.00 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL50KDelivery Order
The Defense Logistics Agency awarded a $2,803.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract, which is a child award under a larger indefinite delivery vehicle, carries an ultimate completion date of June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for the federal government and holds a substantial $999.999 billion indefinite delivery contract with DLA Troop Support Medical through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order for Trulicity, a diabetes management medication, exemplifies the company's ongoing role in fulfilling specific medical commodity needs across the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's contract awards consistently involve firm fixed pricing structures across a diverse therapeutic portfolio, positioning the company as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/17/25 |